老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Milestone Pharmaceuticals Inc.

0.7695
-0.0360-4.47%
成交量：48.47万
成交额：37.73万
市值：9,541.80万
市盈率：-1.14
高：0.8109
开：0.7924
低：0.7510
收：0.8055
52周最高：3.06
52周最低：0.7075
股本：1.24亿
流通股本：1.06亿
量比：0.81
换手率：0.46%
股息：- -
股息率：- -
每股收益(TTM):-0.6748
每股收益(LYR):-0.7517
净资产收益率：-35522.62%
总资产收益率：-42.78%
市净率：5.24
市盈率(LYR):-1.02

数据加载中...

总览公司新闻资讯公告
2021/03/30

重要事件披露

8-K - Current report
2021/03/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/21

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/26

重要事件披露

8-K - Current report
2020/10/23

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/09/22

重要事件披露

8-K - Current report
2020/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/29

重要事件披露

8-K - Current report
更多